Rapid Micro Biosystems reported Q1 2026 revenue of $8.0M (+11.1% YoY), beat analyst consensus of $7.6M by $402.0K. Diluted EPS came in at $-0.31 (-19.2% YoY), missed the $-0.25 consensus by $0.06.
Trailing eight quarters through Q1 2026
Common questions about Rapid Micro Biosystems's Q1 2026 earnings report.
Rapid Micro Biosystems (RPID) reported Q1 2026 earnings on May 13, 2026 before market open.
Rapid Micro Biosystems reported revenue of $8.0M and diluted EPS of $-0.31 for Q1 2026.
Revenue beat the consensus estimate of $7.6M by $402.0K. EPS missed the consensus estimate of $-0.25 by $0.06.
Compared to the same quarter a year prior, revenue grew 11.1% from $7.2M a year earlier and diluted EPS declined 19.2% from $-0.26.
You can read the 8-K earnings release (0001380106-26-000067) and the 10-Q periodic report (0001380106-26-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.